Raily Aesthetic Medicine International Holdings Limited
Climate Impact & Sustainability Data (2022, 2023)
Reporting Period: 2022
Environmental Metrics
Total Carbon Emissions:1074 tonnes of carbon dioxide equivalent
Scope 1 Emissions:23 tonnes of carbon dioxide equivalent
Scope 2 Emissions:1040 tonnes of carbon dioxide equivalent
Scope 3 Emissions:11 tonnes of carbon dioxide equivalent
Renewable Energy Share:Not disclosed
Total Energy Consumption:1574 MWh
Water Consumption:10047 cubic meters
Waste Generated:81 tonnes
Carbon Intensity:6.53 tonnes of carbon dioxide equivalent/million RMB revenue
ESG Focus Areas
- Waste Management
- Energy Consumption
- Greenhouse Gas Emission
- Occupational Health and Safety
- Training and Education
- Operational Compliance
- Quality Management
- Customer Health and Safety
- Customer Service Management
- Information Security
- Customer Privacy Protection
- Responsible Sales and Marketing
Environmental Achievements
- Not disclosed
Social Achievements
- Not disclosed
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Reduce electricity and water consumption by 6% by 2025 (compared to 2021).
Short-term Goals:
- Reduce emissions of air pollutants, wastewater and waste by 5% by 2025 (compared to 2021).
Environmental Challenges
- COVID-19 pandemic impacting normal operation and customer flow.
- Non-fulfillment of profit guarantee for Jiumei Xinhe.
- Increased investment in Suzhou Yonglan R&D with no immediate return.
- Impairment of goodwill of Hangzhou Bellafill due to reduced customer flow.
Mitigation Strategies
- Expansion of flagship stores and introduction of advanced technologies.
- Promoting new concept brands in the aesthetic medical industry.
- Continuous application of a digital management model.
- Expansion of the market share of the facial implant brand.
- Establishment of an R&D and manufacturing platform for advanced aesthetic medical equipment products.
- Vigorous development of sales channels on e-Mall.
Supply Chain Management
Supplier Audits: 38 suppliers; all required to comply with the Group’s supplier management system.
Responsible Procurement
- Product quality, product supply, pricing, reputation, service quality and delivery time considered; preference for products with energy-efficient labels, higher recycling efficiency, less packaging, longer expiry dates; preference for suppliers with ISO50001, ISO14001, ISO26000 certifications.
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Appendix 27 to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:1350 tCO2e/year
Scope 1 Emissions:19 tCO2e/year
Scope 2 Emissions:1127 tCO2e/year
Scope 3 Emissions:14 tCO2e/year
Total Energy Consumption:1682 MWh/year
Water Consumption:9736 m3/year
Waste Generated:73 tonnes/year (non-hazardous), 7 tonnes/year (hazardous)
Carbon Intensity:7.13 tonnes of CO2e/million RMB revenue
ESG Focus Areas
- Environmental Protection
- Employee Management
- Operating Practices
- Community Investment
- Anti-corruption
Environmental Achievements
- Reduced vehicle air pollutant emissions (Nitrogen oxides, Sulfur oxides, Particulate matter) compared to 2022.
- Reduced hazardous waste (7 tonnes in 2023 vs 13 tonnes in 2022).
- Reduced greenhouse gas emissions (1350 tonnes of CO2e in 2023 vs 1074 tonnes in 2022).
Social Achievements
- Increased number of active aesthetic medical clients from approximately 49,900 in 2022 to approximately 55,900 in 2023 (12% increase).
- Improved average consumption per client to approximately RMB 3,100 (3.3% increase from 2022).
- Employed three disabled individuals.
Governance Achievements
- Established clear ESG duties and responsibilities within the Board of Directors.
- Commissioned a third-party ESG professional consultant to assist in stakeholder communication and materiality assessment.
- Formulated an Anti-corruption and Other Fraud Policy.
Climate Goals & Targets
Medium-term Goals:
- Reduce electricity and water consumption by 2% by 2026.
Short-term Goals:
- Reduce emissions of air pollutants, wastewater and waste by 3% by 2026.
Environmental Challenges
- Business affected by the COVID-19 pandemic in the first month of 2023.
- Intensified industry competition.
- Downward trend in Jiumei Xinhe’s performance.
- Delayed product launch cycle for Biotrisse.
- Lack of medical liability insurance.
Mitigation Strategies
- Increased investment in research and development of new medical equipment products.
- Increased marketing and promotion in non-surgical treatments.
- Expansion of RAILY urban flagship institutions.
- Application of digital management model.
- Establishment of a new medical technology exchange platform.
- Increased marketing efforts and enhanced diversity of online marketing.
- Expansion of market share of aesthetic medical equipment products.
- Establishment of an R&D and manufacturing platform for advanced aesthetic medical equipment products.
Supply Chain Management
Supplier Audits: 75 suppliers (88% from China, 12% from rest of the world)
Responsible Procurement
- Procurement Management Policy; green procurement; priority to suppliers with ISO 50001, ISO 14001, and low-carbon product certifications; priority to suppliers with ISO 26000.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: Appendix C2 to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited